Hartford Investment Management Co. Has $3.24 Million Position in HCA Healthcare Inc (HCA)
Hartford Investment Management Co. lessened its position in HCA Healthcare Inc (NYSE:HCA) by 40.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 31,595 shares of the company’s stock after selling 21,361 shares during the period. Hartford Investment Management Co.’s holdings in HCA Healthcare were worth $3,242,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Bank of Montreal Can increased its holdings in shares of HCA Healthcare by 49.5% in the 2nd quarter. Bank of Montreal Can now owns 506,077 shares of the company’s stock worth $51,922,000 after acquiring an additional 167,599 shares during the period. NN Investment Partners Holdings N.V. increased its holdings in shares of HCA Healthcare by 198.9% in the 2nd quarter. NN Investment Partners Holdings N.V. now owns 170,204 shares of the company’s stock worth $17,463,000 after acquiring an additional 113,265 shares during the period. Summit Trail Advisors LLC increased its holdings in shares of HCA Healthcare by 9,933.3% in the 1st quarter. Summit Trail Advisors LLC now owns 112,774 shares of the company’s stock worth $113,000 after acquiring an additional 111,650 shares during the period. Knightsbridge Asset Management LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter worth about $10,711,000. Finally, Millennium Management LLC increased its holdings in shares of HCA Healthcare by 1,630.4% in the 4th quarter. Millennium Management LLC now owns 105,417 shares of the company’s stock worth $9,260,000 after acquiring an additional 99,325 shares during the period. 70.91% of the stock is currently owned by institutional investors and hedge funds.
In other news, SVP Deborah M. Reiner sold 1,204 shares of the firm’s stock in a transaction dated Tuesday, June 5th. The shares were sold at an average price of $105.00, for a total transaction of $126,420.00. Following the completion of the transaction, the senior vice president now owns 3,432 shares in the company, valued at approximately $360,360. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,750 shares of the firm’s stock in a transaction dated Wednesday, June 13th. The shares were sold at an average price of $106.87, for a total transaction of $187,022.50. Following the transaction, the senior vice president now owns 9,494 shares of the company’s stock, valued at approximately $1,014,623.78. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 51,974 shares of company stock valued at $5,511,523. Insiders own 2.80% of the company’s stock.
HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, May 1st. The company reported $2.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.07 by $0.26. HCA Healthcare had a net margin of 5.96% and a negative return on equity of 55.50%. The firm had revenue of $11.42 billion for the quarter, compared to analysts’ expectations of $11.29 billion. During the same quarter last year, the company earned $1.74 EPS. HCA Healthcare’s quarterly revenue was up 7.5% on a year-over-year basis. research analysts forecast that HCA Healthcare Inc will post 8.83 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 29th. Stockholders of record on Friday, June 1st were given a dividend of $0.35 per share. The ex-dividend date was Thursday, May 31st. This represents a $1.40 annualized dividend and a dividend yield of 1.30%. HCA Healthcare’s dividend payout ratio (DPR) is 21.24%.
A number of analysts recently weighed in on HCA shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $115.00 price objective on shares of HCA Healthcare in a report on Friday. SunTrust Banks reissued a “buy” rating and set a $125.00 target price on shares of HCA Healthcare in a research note on Friday. ValuEngine raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Wednesday, July 18th. Zacks Investment Research raised shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $119.00 target price on the stock in a research note on Monday, July 16th. Finally, Morgan Stanley raised their target price on shares of HCA Healthcare from $91.00 to $98.00 and gave the company an “underweight” rating in a research note on Friday, July 13th. Three analysts have rated the stock with a sell rating, six have given a hold rating and seventeen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $107.16.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Story: Book Value Of Equity Per Share – BVPS Explained
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.